Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
migraine
5
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
5
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
eli lilly
fda
cancer
cancer immunotherapy
gene therapy
lasmiditan
novartis
teva pharmaceutical
american academy of neurology
biogen
crispr
What
bio
roundup
companies
new
approval
drug
drugs
ipo
life
science
week
america
arena’s
arguments
bails
big
biogen
biogen’s
biopharmaceutical
bounty
brand
bridgebio
capital
car
cig
class
comeback
commercialized
competitors
continues
convo
convoluted
corner
deals
decades
delivered
democrats
develop
dreams
earlier
Language
unset
Current search:
migraine
×
biotech
×
" san diego top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More